By Lisa Thompson OTC:CLPMF READ THE FULL CLPMF RESEARCH REPORT Revenue is ramping even faster than we expected, as shown by the Q3 earnings report. Revenue for Q3 2024 was $521,000 compared to $149,000 in Q3 of 2023, representing 250% growth. In the quarter, the number of new deposit users grew by 101%, and revenue … Read more
By Brad Sorensen, CFA OTC:BSEM READ THE FULL BSEM RESEARCH REPORT We don’t often write about short-term movements in stocks we cover but the move in BioStem Technologies, Inc. (OTC:BSEM) has coincided with what seems to have been perceived as a fundamental change in the company and we want to make sure investors know the … Read more
By Michael Kim NASDAQ:BENF READ THE FULL BENF RESEARCH REPORT After the market closed on 11/14/24, Beneficient (NASDAQ:BENF) reported F2Q25 (Sep) earnings results. On a GAAP basis, BENF reported net income of $0.03 per Class A diluted share for F2Q25 – the company’s second consecutive profitable quarter as a public company – versus a loss … Read more
By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company’s AI models, novel targets within … Read more
By M. Marin NYSE:AMS READ THE FULL AMS RESEARCH REPORT Full quarter consolidation Rhode Island, some contribution from Puebla, anticipate 6.7% Q/Q 3Q24 revenue increase American Shared Hospital Services’ (NYSE:AMS) will report 3Q24 results on November 13, 2024, and hold a conference call that day at 1:00 pm ET. The company provides stereotactic radiosurgery equipment … Read more
